Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 1997

View Archived Issues

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

Exactech and the University of Florida Tissue Bank to codevelop biologic bone repair material

Discovery of potent and selective mu-opiate receptor agonists

Schering-Plough and Myriad Genetics enter into strategic collaboration

Sobel to acquire majority interest in Sidmak Laboratories

Matrix initiates phase II trial of IntraDose in liver cancer

Glaxo Wellcome discovers potent BAT inhibitor

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

VIMRx completes phase I studies for VIMRxyn

Positive phase III results from Hyal's actinic keratosis trial

Cardiovascular Diagnostics and Lilly enter into development agreement

Novopharm and Glaxo Wellcome reach agreement for ranitidine

Altarex receives funding for photodynamic therapy for ovarian cancer research

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

Potential new treatments highlighted at recent periodontology symposium

Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux

Emisphere receives notices of allowance for oral delivery technologies

Potent TNF inhibitor described by Celgene

Xoma and Pfizer discontinue U.S. phase III trial of E5

Parke-Davis SAR studies lead to potent, selective D4 antagonist

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

RPR describes novel farnesyltransferase inhibitors

Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders

Axcan receives IND approval for URSO in hypercholesterolemia

Matrix Pharmaceutical announces marketing partner for AccuSite in Spain and Portugal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...